Cancer Biomarkers

Papers
(The TQCC of Cancer Biomarkers is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Involvement of FAM170B-AS1 , hsa-miR-1202 , and hsa-miR-146a-5p 84
KIAA1429-mediated RXFP1 attenuates non-small cell lung cancer tumorigenesis via N6-methyladenosine modification48
Preoperative albumin-alkaline phosphatase ratio affects the prognosis of patients undergoing hepatocellular carcinoma surgery34
The clinical significance and function of EGFR mutation in TKI treatments of NSCLC patients30
Individual recombinant repeats of MUC16 display variable binding to CA125 antibodies18
miR-383-5p serves as a tumor suppressor in bladder cancer by suppressing PI3K/AKT signaling pathway17
RAB27B expression in pancreatic cancer is predictive of poor survival but good response to chemotherapy16
The effect of low-intensity resistance exercise training on Serum tumor biomarkers and quality of life in women with breast cancer: A randomized controlled trial15
Integrative analysis of histone acetyltransferase KAT2A in human cancer14
Impact of the peripheral blood inflammatory indices and modified nomogram-revised risk index on survival of Extranodal Nasal-Type Natural Killer/T-Cell lymphoma14
GINS2 promotes the progression of human HNSCC by altering RRM2 expression14
KLF5 inhibits the migration and invasion in cervical cancer cell lines by regulating SNAI114
Machine learning identifies a 5-serum cytokine panel for the early detection of chronic atrophy gastritis patients12
Identification of a novel necroptosis-related LncRNA signature for prognostic prediction and immune response in oral squamous cell carcinoma12
Identification of TNFRSF1A as a potential biomarker for osteosarcoma12
Erratum to: Annexin A5 overexpression might suppress proliferation and metastasis of human uterine cervical carcinoma cells11
YTHDF1 amplification is correlated with worse outcome and lower immune cell infiltrations in breast cancer11
Multi-omics pan-cancer analysis of monocyte to macrophage differentiation-associated (MMD) and its significance in hepatocellular carcinoma10
TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients10
High TCTA expression is an adverse prognostic biomarker in acute myeloid leukemia10
Analysis of clinical significance and molecular characteristics of methionine metabolism and macrophage-related patterns in hepatocellular carcinoma based on machine learning9
Identification of candidate biomarkers and prognostic analysis of recurrence in colorectal cancer9
SLAMF8 expression and prognostic significance in melanoma: A multi-omics and Mendelian randomization study9
A pilot study to troubleshoot quality control metrics when assessing circulating miRNA expression data reproducibility across study sites9
Albumin-bilirubin score predicts trastuzumab resistance in HER2-positive breast cancer9
Assessing the clinical utility of biomarkers using the intervention probability curve (IPC)9
Down-regulated MiRNA 29-b as a diagnostic marker in colorectal cancer and its correlation with ETV4 and Cyclin D1 immunohistochemical expression9
The overexpression of HOXC6 in LUSC and pan-squamous cell carcinomas indicates the coexistence of nuclear division regulatory mechanisms9
CHRDL1, NEFH, TAGLN and SYNM as novel diagnostic biomarkers of benign prostatic hyperplasia and prostate cancer8
Investigating whether exosomal miR-205-5p derived from tongue squamous cell carcinoma cells stimulates the angiogenic activity of HUVECs by targeting AMOT8
Bidirectional Mendelian randomization analysis reveals significant associations between Serum DNA repair proteins and liver cancer8
EGFR, HLA-G, CD70, c-MET, and NY-ESO1 as potential biomarkers in high grade epithelial ovarian carcinoma8
Machine learning reveals the role of telomerase activation-related genes in the prognosis of neuroblastoma8
CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML8
From discovery to clinical implementation of a pancreatic blood biomarker, apolipoprotein A2 isoform8
A risk model based on signature genes predicts prognosis and associates with tumor immunity, drug sensitivity in breast cancer8
Expression of serum HMGB1, SAA, and TSGF in patients with colon cancer and the value of prognostic assessment8
Lower subcutaneous fat index predicts bone metastasis in breast cancer7
Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis7
ELAPOR1 suppresses tumor progression in colorectal cancer and indicates favorable prognosis7
Prognosis of keratinizing squamous cell carcinoma of the female reproductive system: A retrospective study7
The prognostic significance of DDIT4 in endometrial cancer7
Retraction to: Schizandrin A inhibits proliferation, migration and invasion of thyroid cancer cell line TPC-1 by down regulation of microRNA-4297
A novel disulfidptosis-related prognostic gene signature and experimental validation identify ACTN4 as a novel therapeutic target in lung adenocarcinoma7
Identification of prognostic biomarkers among ICAMs in the breast cancer microenvironment7
Prognostic value and gene regulatory network of CMSS1 in hepatocellular carcinoma7
A simplified MyProstateScore2.0 for high-grade prostate cancer7
The ratio of lymphocyte/red blood cells and platelets/lymphocytes are predictive biomarkers for lymph node metastasis in patients with breast cancer7
External validation of CEA and CA125 prediction model for lymph node metastasis in endometrial cancer: A multi-institute cohort study7
The combined detection of hematological indicators is used for the differential diagnosis of colorectal cancer and benign-colorectal lesions7
TRB CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinoma7
Deep learning approaches for breast cancer detection in histopathology images: A review7
Prognostic characterization of the pyroptosis-related subtypes and tumor microenvironment infiltration in glioma7
Uncovering the link between human endogenous retroviruses, inflammatory pathways, and gastric cancer development7
Blood endocan as a biomarker for breast cancer recurrence6
Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practice6
The effect of chromosome abnormalities on expression of SnoRNA in radioresistant and radiosensitive cell lines after irradiation6
Serum CA19-9 as a predictor of incident metabolic syndrome in obese middle-aged and older men: A 9-year cohort study6
Prognostic value of ALK overexpression and molecular abnormalities in high-grade serous ovarian carcinoma6
The association between pain and WHO grade of pancreatic neuroendocrine neoplasms: A multicenter study6
Knockdown of MACC1 expression attenuates colorectal cancer cell glucose metabolism by suppressing GLUT4 membrane translocation6
Retraction to: Knockdown of USP39 by lentivirus-mediated RNA interference suppresses the growth of oral squamous cell carcinoma6
Association of 21-gene recurrence score and locoregional recurrence in early breast cancer patients6
Upregulated mitosis-associated genes CENPE, CENPF, and DLGAP5 predict poor prognosis and chemotherapy resistance of Acute Myeloid Leukemia5
TUBB3 (βIII-tubulin) drives gastric cancer progression and poor prognosis by regulating cell cycle and invadopodia formation5
Tumour microbiota activities associated with local recurrence in ER + PR + breast cancer5
Assessing the prognostic value of IMDC risk score for nivolumab-treated patients with renal cancer and malignant melanoma5
Salivary DNA methylation markers for cancer of oral cavity5
A new immune-related gene signature predicts the prognosis and immune escape of bladder cancer5
The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma5
CmP signaling network unveils novel biomarkers for triple negative breast cancer in African American women5
Subcutaneous fat predicts bone metastasis in breast cancer: A novel multimodality-based deep learning model5
Combination detection of IgG- and IgA-related autoantibodies for the early diagnosis of gastric cancer5
Identification of a prognostic signature based on five ferroptosis-related genes for diffuse large B-cell lymphoma5
Identification of metabolic biomarkers for diagnosis of epithelial ovarian cancer using internal extraction electrospray ionization mass spectrometry (iEESI-MS)5
Retraction to: MicroRNA-1246 inhibits cell invasion and epithelial mesenchymal transition process by targeting CXCR4 in lung cancer cells5
Non-invasive prediction of DCE-MRI radiomics model on CCR5 in breast cancer based on a machine learning algorithm5
Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type4
Prognostic value of an eighteen-genes panel in acute myeloid leukemia by analyzing TARGET and TCGA databases4
Internalization of extracellular double-stranded DNA as a potential marker of cancer stem cells in Epstein–Barr virus-induced B-cell lymphoma4
Retraction to: LINC01638 lncRNA promotes the proliferation, migration and invasion of prostate carcinoma cells by interacting with Notch14
Elevated expression patterns of P-element Induced Wimpy Testis (PIWI) transcripts are potential candidate markers for Hepatocellular Carcinoma4
Identification of RNA-binding protein RBMS3 as a potential biomarker for immunotherapy in bladder cancer4
Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab4
A comprehensive analysis of mRNA expression profiles of Esophageal Squamous Cell Carcinoma reveals downregulation of Desmoglein 1 and crucial genomic targets4
Retraction to: MicroRNA-152 inhibits tumor cell growth while inducing apoptosis via the transcriptional repression of cathepsin L in gastrointestinal stromal tumor4
PDCD2L overexpression represents an unfavorable prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer4
Pulmonary adenocarcinoma of low malignant potential defines indolent NSCLC associated with overdiagnosis in the national lung screening trial4
Diagnostic utility of lipocalin 2 and metalloproteinase 9 levels in early-stage endometrial cancer4
RANK in cancer-associated fibroblasts: A valuable prognostic determinant for metastasis in early-stage breast cancer patients4
EMP3: A promising biomarker for tumor prognosis and targeted cancer therapy4
Hypermethylation of the BRCA2 gene promoter and its co-hypermethylation with the BRCA1 gene promoter in pa4
Expression and clinical significance of TYRP1, ABCB5, and MMP17 in sinonasal mucosal melanoma4
Radiomics and artificial intelligence for risk stratification of pulmonary nodules: Ready for primetime?4
A novel cuproptosis-related lncRNA signature predicts the prognosis and immunotherapy for hepatocellular carcinoma4
Hsa_circ_0101308 adjusted by N6-methyladenosine (m 6 A) impacts chemo-resistance in cervical cancer via sponging miR-2244
Advances in SEMA3F regulation of clinically high-incidence cancers4
Identification of DNA methylation-regulated WEE1 with potential implications in prognosis and immunotherapy for low-grade glioma4
The importance of biglycan, decorin and TGF-1 levels in the diagnosis of non-small cell lung cancer4
Estimated proportion of cancer deaths not addressed by current cancer screening efforts in the United States4
Clinical significance of “S” isoform of DCLK1 in different gastric cancer subtypes using newly produced monoclonal antibody4
Changes in subcellular localization of Lysyl-tRNA synthetase and the 67-kDa laminin receptor in epithelial ovarian cancer metastases4
Prediction for recurrent non-muscle invasive bladder cancer4
0.1205849647522